<DOC>
	<DOCNO>NCT01166659</DOCNO>
	<brief_summary>The purpose study evaluate safety effectiveness CyPass implantation stand-alone therapy lower intraocular pressure ( IOP ) patient primary open angle glaucoma ( POAG ) fail least one class topical medical therapy</brief_summary>
	<brief_title>Study CyPass Implantation In Patients With Open Angle Glaucoma Refractory Single Multi-agent Topical Therapy</brief_title>
	<detailed_description />
	<mesh_term>Glaucoma</mesh_term>
	<mesh_term>Glaucoma , Open-Angle</mesh_term>
	<criteria>Diagnosis POAG Medicated IOP ≥ 21 ≤ 35 mmHg Use 1 4 topical IOP lower medication Acute angle closure , traumatic , congenital , malignant , uveitic neovascular glaucoma Use oral hypotensive medication treatment glaucoma Previous incisional glaucoma surgery , combine cataractglaucoma procedure Clinically significant ocular pathology POAG</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>99 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Glaucoma</keyword>
	<keyword>Glaucoma device</keyword>
	<keyword>Glaucoma surgery</keyword>
	<keyword>Intraocular pressure</keyword>
</DOC>